OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Pharmacokinetics of Semaglutide: A Systematic Review
Xi‐Ding Yang, Xi‐Ding Yang
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2555-2570
Open Access | Times Cited: 14

Showing 14 citing articles:

Considering the use of GLP-1 receptor agonists in women with obesity prior to pregnancy: a narrative review
Sarah Price, Alison Nankervis
Archives of Gynecology and Obstetrics (2025)
Open Access | Times Cited: 1

Critical updates on oral insulin drug delivery systems for type 2 diabetes mellitus
Chai L. Low, Wei Gan, Silvia Lai, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Advances in Oral Biomacromolecule Therapies for Metabolic Diseases
Qiuxia Jiao, Yuan Huang, Jinhan He, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 238-238
Open Access

The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects
Yue Liu, Wei Chen, Xuemei He, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access

The Effect of Oral Semaglutide on Cardiovascular Risk Factors in Patients with Type 2 Diabetes: A Systematic Review
Stanislaus Ivanovich Krishnanda, Marie Christabelle, Oliver Emmanuel Yausep, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2239-2239
Open Access

Oxytocin lipidation expanding therapeutics for long-term reversal of autistic behaviors in rats
Honglin Li, Ya Chen, Yue Qiu
International Journal of Pharmaceutics (2025), pp. 125299-125299
Closed Access

The limitation of lipidation: conversion of semaglutide from once-weekly to once-monthly dosing
Eric L. Schneider, John A. Hangasky, Rocio del Valle Fernandez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

The limitation of lipidation: Conversion of semaglutide from once-weekly to once-monthly dosing
Eric L. Schneider, John A. Hangasky, Rocío del Valle Fernández, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 47
Open Access | Times Cited: 2

GLP-1 Receptor Agonists and the Risk of Postoperative Nausea and Vomiting after Laparoscopic Sleeve Gastrectomy:A Single-Center, Retrospective Cohort Study
Xiaodong Shan, Yongjin Wang, Xiaoao Xiao, et al.
Surgery for Obesity and Related Diseases (2024)
Closed Access | Times Cited: 1

Engineering Supramolecular Nanofiber Depots from a Glucagon-Like Peptide-1 Therapeutic
Weike Chen, Sijie Xian, Bernice Webber, et al.
ACS Nano (2024)
Closed Access | Times Cited: 1

Exploring the Impact of Semaglutide on Cognitive Function and Anxiety-Related Behaviors in a Murine Model of Alzheimer’s Disease
Ianis Kevyn Stefan Boboc, Petrica-Daniel Dumitrelea, Andreea-Daniela Meca, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2689-2689
Open Access

Glucagon-like peptide-1 receptor agonists in peri-operative care
Larissa Paggers, Dieter Mesotten, Hendrik Stragier
European Journal of Anaesthesiology (2024)
Closed Access

Weight control issues: perspectives in aesthetic medicine
Л. С. Круглова, A. V. Tamrazova
Medical alphabet (2024), Iss. 25, pp. 8-12
Closed Access

An exploratory analysis of glucagon‐like peptide‐1 (GLP‐1) agonists and biosimilars: A literature review
Jimmy Wen, Adam A Razick, Christiane How‐Volkman, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access

Page 1

Scroll to top